Pet Boarding Seminar Tour Kicks Off In MayApril 29, 2011 Laura Laaman & Associates, a business training and consulting agency based in Wilton, Conn., plans to host in May a four-city seminar tour for the pet lodging industry. The Revenue Boot Camp seminar tour aims to provide pet lodging professionals with sales tools and business techniques along with enhanced pet care services and strategies to increase profits. It is open to owners and managers of pet boarding facilities and day care centers and veterinarians who provide non-medical boarding. Topics covered during Revenue Boot Camp include: • Selling activities and other add-on’s • How to turn a phone call into a reservation • 10 ways to beat the competition • Running a profitable referral campaign Tour dates are: • Tuesday, May 3, Stamford, Conn. • Wednesday, May 4, Boston • Thursday, May 5, Orlando, Fla. • Wednesday, May 11, San Francisco Tickets are still available at the reduced price of $795. Revenue Boot Camp is guaranteed to produce results or attendees will receive a full refund. For more information, click here. <Home>
SPONSORED CONTENTCurrent users report reduced stress for parvovirus care1Research shows that our Canine Parvovirus Monoclonal Antibody can help veterinary care teams work with less stress.1 Learn what CPMA can do for your parvo protocol. + Read More
AVMA Seeks Input On Report Outlining Next DecadeApril 29, 2011 The American Veterinary Medical Association reported this week that it is seeking comments on its recently released AVMA 20/20 Vision Commission’s report. The report is designed to offer a roadmap for the next decade of veterinary medicine, according to the AVMA. The report lays out goals and strategies in 11 areas pertinent to veterinary medicine, including social responsibility, global outreach, diversity and financial stability for the profession. “With the AVMA entering an unprecedented era of change, it is essential to have a new vision and roadmap to ensure that the association is relevant and responsive to its members and the public over the next decade,” said Lonnie King, DVM, dean of The Ohio State University College of Veterinary Medicine, who chaired the commission. As outlined in the plan, by 2020, AVMA should have: • Achieved a new level of social responsibility and helped meet societal needs; • Become more influential—externally focused, spanned boundaries and sparked a new public awareness of the profession’s many contributions to society; • Helped drive improved economic performance and long-term financial stability for the entire profession; • Balanced its relationships with an increasingly complex …
Pfizer Discontinues Periodontitis VaccineApril 29, 2011 Pfizer Animal Health’s canine Porphyromonas vaccine has been discontinued, effective early April 2011, due to efficacy issues. The product was designed as an aid to preventing periodontitis. The Porphyromonas Denticanis-Gulae-Salivosa Bacterin vaccine was conditionally licensed by the U.S. Department of Agriculture in September 2006. Since then, the Madison, N.J.-based company has conducted a 48-month field efficacy study intended to support the full licensure of this product. Although the study confirmed the vaccine’s safety, it “did not demonstrate a vaccine effect in vaccinates (as compared to controls) for either of the key efficacy variables assessed (attachment loss and gingival bleeding index),” according to a letter sent to veterinarians in early March by Oliver Knesl, BVSc, MRCVS, marketing manager of companion animal biologicals at Pfizer Animal Health. On the basis of these results, Pfizer Animal Health will not pursue renewal of the current conditional license for the vaccine, Sherry Podhayny, VMD, told Veterinary Practice News. Dr. Podhayny is the manager of veterinary operations of companion animal biologicals at Pfizer Animal Health. Any product still in inventory can continue to be administered safely until product expiration, she said. The company has produced a pet owner communication …
Update: Pfizer Discontinues Periodontitis VaccineApril 29, 2011UPDATE: 4/28/11 -- Pfizer Animal Health’s canine Porphyromonas vaccine has been discontinued, effective early April 2011, due to efficacy issues. The product was designed as an aid to preventing periodontitis. The Porphyromonas Denticanis-Gulae-Salivosa Bacterin vaccine was conditionally licensed by the U.S. Department of Agriculture in September 2006. Since then, the Madison, N.J.-based company has conducted a 48-month field efficacy study intended to support the full licensure of this product. Although the study confirmed the vaccine’s safety, it “did not demonstrate a vaccine effect in vaccinates (as compared to controls) for either of the key efficacy variables assessed (attachment loss and gingival bleeding index),” according to a letter sent to veterinarians in early March by Oliver Knesl, BVSc, MRCVS, marketing manager of companion animal biologicals at Pfizer Animal Health. On the basis of these results, Pfizer Animal Health will not pursue renewal of the current conditional license for the vaccine, Sherry Podhayny, VMD, told Veterinary Practice News. Dr. Podhayny is the manager of veterinary operations of companion animal biologicals at Pfizer Animal Health. Any product still …
VCA Antech Sees Same-Store Revenue Drop By 2.2% In Q1April 28, 2011 VCA Antech Inc.’s animal division reported revenue of $269.9 million for its first quarter ended March 31, compared to revenue of $246.7 million in the year-ago period. The 9.4 percent increase was driven by acquisitions made in the past 12 months, said Bob Antin, chairman and CEO of the company. VCA Antech’s same-store revenue declined by 2.2 percent while its same-store gross profit margin declined to 14.9 percent from 16.9 percent, according to Antin. During the quarter, VCA Antech acquired two animal hospitals which had historical combined annual revenue of $4.8 million. VCA Antech’s laboratory division reported revenue of $79.5 million for its first quarter, compared to revenue of $78.2 million in the year-ago period. The medical technology division reported revenue of $19.1 million for its first quarter, compared to revenue of $15.8 million in the year-ago period. Overall, the Los Angeles-based company reported net income of $30.5 million on revenue of $355.1 million for the first quarter, compared to net income of $32.9 million on revenue of $330.7 million in the year-ago period. VCA Antech reaffirmed its fiscal year 2011 guidance: revenue from $1.47 billion to $1.51 billion and net income from …
Canine Fashion Show To Benefit Underprivileged PetsApril 28, 2011 The Colorado Veterinary Medical Foundation will host its 10th Annual Mutts and Models—The Fundraiser for Underprivileged Pets on Saturday, May 21, in Denver. The theme of this year’s canine and celebrity fashion show is Breakfast at Sniffany’s. More than 400 people are expected to attend the “black-collar” event, according to the foundation. Guests will watch local philanthropists, celebrities and media personalities strut down the runway with their dogs. There will also be a live and silent auction, among other activities. All proceeds from the event will go to the Harrison Memorial Animal Hospital, which provides veterinary care for pets of the economically disadvantaged. For details, click here. <Home>
Florida Launches Certified Vet Assistant ProgramApril 28, 2011 The Florida Veterinary Medical Association has adopted a certified veterinary assistant program. The program is Web-based and will be comprised of four key elements: educational online curriculum, practical experience of on-the-job training, validation of 100 skills to be checked off by a veterinarian or registered veterinary technician and the online final examination. The program includes more than 200 staff training videos provided by Animal Care Technologies (ACT). The Denton, Texas-based company has been offering training programs for the veterinary industry for 15 years and providing industry certification programs in several other states, including California, Missouri, Texas and Iowa. “It is very important that Florida creates a career opportunity early on for the staff member,” said David Grant, DVM, of ACT. “Often times, the veterinary assistant position has a very high turnover rate, about 44 percent nationwide. By earning this credential, you give the employee a mindset that they are embarking on a career not just a job.” Individuals can learn more about the certification program at the annual Florida Veterinary Medical Association meeting, to be held April 29 – May 1 in Orlando, Fla. Details can also be found at fvma.4act.com or by calling …
Pet Owners Favor Adoption, Survey SaysApril 27, 2011 A person looking for his or her next pet is more likely to go to an animal shelter or rescue than a pet store, according to a survey released yesterday by Hartz Mountain Corp. of Secaucus, N.J. The Hartz Pet Trend Report, conducted by Richard Day Research, polled 1,028 U.S. cat and dog owners about their pet and pet-related topics. It found that 60 percent of the respondents would prefer to adopt their next pet from a rescue society, while 10 percent said they’d go to a registered breeder, 4 percent said they’d go to a pet store and another 4 percent said it wouldn’t matter. Hartz said it commissioned the survey to better understand what pet owners think about pet issues and to gain insight into pet owners’ relationships with their four-legged companions. When considering what makes a good pet, the majority of pet owners polled (65 percent) said personality is the most important characteristic, followed by loyalty (20 percent), obedience (11 percent), “something else” (2 percent) and purity of breed (1 percent). < The release of the Hartz Pet Trend Report coincides with National Pet Week, scheduled for May 1 to 7, 2011. …
First World Feline Veterinary Conference Set For SeptemberApril 26, 2011 The American Association of Feline Practitioners and the International Society of Feline Medicine will introduce the 1st World Feline Veterinary Conference on Sept. 8-11 in Boston. The theme will be "Cardiovascular Disease: The Heart of Feline Medicine." The conference is geared for veterinarians, veterinary technicians and students from varied clinical backgrounds who are interested in learning about feline cardiology. “Feline health and wellness is a global issue,” said Roberta Lillich, DVM, the AAFP program committee chair and past president. “The 2011 conference will bring together practitioners from all over the world, giving us the opportunity to make a difference by working together.” The event will include 42 exhibiting companies as well as feline focused seminars. Twenty-one general continuing education credits and four additional ancillary continuing education credits will be offered. For details, click here. <Home>
European Commission Approves 2 New Bayer Animal Health ProductsApril 26, 2011 Bayer Animal Health reported today that it is expanding its international companion animal portfolio with two new European Commission-approved products: Veraflox (pradofloxacin) and Procox (emodepside and toltrazuril). The company describes Veraflox as the first next-generation veterinary fluoroquinolone antibiotic for the treatment of bacterial infection in dogs and cats. The European Commission granted approval for the treatment of the following infections caused by specified and susceptible pathogens: wound infections, superficial and deep pyoderma, acute urinary tract infections and as adjunctive treatment for severe gingival and periodontal tissue infections in dogs; and against wound infections, abscesses and acute upper respiratory tract infections in cats. The product is available in flavored tablets for dogs and cats as well as an oral suspension for cats. Veraflox is approved in 30 European countries and will be launched in the first markets “shortly,” according to Bayer Animal Health. Procox is the first and only licensed combination treatment for roundworm and coccidia gastrointestinal parasitic infections in dogs, according to the company. This includes puppies of at least two weeks of age and weighing at least 0.9 pounds. The product is available as an oral suspension. Procox is approved in …
